IL113979A0 - Process for preparing cardiodilatin fragments highly purified cardiodilatin fragments and intermediate products for the preparation of same - Google Patents

Process for preparing cardiodilatin fragments highly purified cardiodilatin fragments and intermediate products for the preparation of same

Info

Publication number
IL113979A0
IL113979A0 IL11397995A IL11397995A IL113979A0 IL 113979 A0 IL113979 A0 IL 113979A0 IL 11397995 A IL11397995 A IL 11397995A IL 11397995 A IL11397995 A IL 11397995A IL 113979 A0 IL113979 A0 IL 113979A0
Authority
IL
Israel
Prior art keywords
preparation
cardiodilatin fragments
fragments
highly purified
same
Prior art date
Application number
IL11397995A
Other languages
English (en)
Original Assignee
Corange Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19513784A external-priority patent/DE19513784A1/de
Application filed by Corange Int Ltd filed Critical Corange Int Ltd
Publication of IL113979A0 publication Critical patent/IL113979A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL11397995A 1994-06-02 1995-06-01 Process for preparing cardiodilatin fragments highly purified cardiodilatin fragments and intermediate products for the preparation of same IL113979A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4420381 1994-06-02
DE19513784A DE19513784A1 (de) 1994-06-02 1995-04-10 Hochreines Urodilatin und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
IL113979A0 true IL113979A0 (en) 1995-10-31

Family

ID=25937342

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11397995A IL113979A0 (en) 1994-06-02 1995-06-01 Process for preparing cardiodilatin fragments highly purified cardiodilatin fragments and intermediate products for the preparation of same

Country Status (8)

Country Link
US (5) US5767239A (xx)
EP (1) EP0763061B1 (xx)
JP (2) JPH10500969A (xx)
AT (1) ATE226960T1 (xx)
AU (1) AU2671795A (xx)
ES (1) ES2188665T3 (xx)
IL (1) IL113979A0 (xx)
WO (1) WO1995033769A1 (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0763061B1 (de) * 1994-06-02 2002-10-30 Forssmann, Wolf-Georg, Prof. Dr. med. Verfahren zur herstellung von cardiodilatin-fragmenten, hochgereinigte cardiodilatin-fragmente und zwischenprodukte zu deren herstellung
EP1118329A4 (en) * 1998-09-28 2004-12-15 Santen Pharmaceutical Co Ltd LACRYMAL SECRETION PROMOTERS OR OPHTHALMOLOGICAL DROPS CONTAINING NATRIURETIC PEPTIDES AS ACTIVE INGREDIENTS FOR TREATING KERATOCONJUNCTIVITY
UA71608C2 (en) * 1999-03-11 2004-12-15 Merck Patent Gmbh A method for producing the cyclic pentapeptide
JP4874954B2 (ja) 2004-04-21 2012-02-15 エノビア ファーマ インコーポレイティド 骨送達複合体ならびにタンパク質に骨を標的化させるためのその使用方法
CA2582083A1 (en) * 2004-10-04 2006-04-20 Novetide, Ltd. A counterion exchange process for peptides
WO2006110743A1 (en) 2005-04-07 2006-10-19 Cardiopep Pharma Gmbh Use of natriuretic peptide for treating heart failure
EP2171053B1 (en) * 2007-07-20 2014-04-23 Mayo Foundation for Medical Education and Research Natriuretic polypeptides
EP2234603A1 (en) * 2007-12-19 2010-10-06 EKR Therapeutics, Inc. Room temperature stable, lyophilized natriuretic peptide formulations
US9266939B2 (en) 2010-12-27 2016-02-23 Alexion Pharmaceuticals, Inc. Compositions comprising natriuretic peptides and methods of use thereof
WO2013103896A1 (en) 2012-01-06 2013-07-11 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
JP6108858B2 (ja) 2012-02-17 2017-04-05 株式会社半導体エネルギー研究所 ｐ型半導体材料および半導体装置
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US20140213519A1 (en) 2013-01-25 2014-07-31 Cardiorentis Ltd. Methods of treating cardiovascular indications
CN103145827A (zh) * 2013-03-04 2013-06-12 吉尔生化（上海）有限公司 一种乌拉力肽的固相合成方法
WO2016007873A1 (en) 2014-07-11 2016-01-14 The Regents Of The University Of Michigan Compositions and methods for treating craniosynostosis
RU2708068C2 (ru) 2014-12-05 2019-12-04 Алексион Фармасьютикалз, Инк. Лечение судорог с использованием рекомбинантной щелочной фосфатазы
JP6868561B2 (ja) 2015-01-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼ欠損を有する被験者を治療する方法
WO2016131943A1 (en) 2015-02-20 2016-08-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of obesity and complications arising therefrom including type 2 diabetes
RU2745528C2 (ru) 2015-08-17 2021-03-26 Алексион Фармасьютикалз, Инк. Производство щелочных фосфатаз
EP3355904A4 (en) 2015-09-28 2019-06-12 Alexion Pharmaceuticals, Inc. IDENTIFICATION OF EFFECTIVE DOSE SHEETS FOR TISSUE-SPECIFIC ALKALINE PHOSPHATASE ENZYMERSAT THERAPY OF HYPOPHOSPHATASIA
US11400140B2 (en) 2015-10-30 2022-08-02 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
CN106928342B (zh) * 2015-12-31 2020-10-16 深圳翰宇药业股份有限公司 一种乌拉立肽的制备方法
WO2017155569A1 (en) 2016-03-08 2017-09-14 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
EP3436020A4 (en) 2016-04-01 2019-12-25 Alexion Pharmaceuticals, Inc. METHOD FOR TREATING HYPOPHOSPHATASIE IN TEENS AND ADULTS
MX2018011833A (es) 2016-04-01 2019-02-13 Alexion Pharma Inc Tratamiento para la debilidad muscular con fosfatasas alcalinas.
EP3464573A4 (en) 2016-06-06 2020-02-19 Alexion Pharmaceuticals, Inc. IMPACT OF METAL ON THE PRODUCTION OF ALKALINE PHOSPHATASES
WO2018035420A1 (en) 2016-08-18 2018-02-22 Alexion Pharmaceuticals, Inc. Methods for treating tracheobronchomalacia
KR20190129058A (ko) 2017-03-31 2019-11-19 알렉시온 파마슈티칼스, 인코포레이티드 성인 및 청소년에서 저포스파타제증 (hpp)을 치료하는 방법
US11913039B2 (en) 2018-03-30 2024-02-27 Alexion Pharmaceuticals, Inc. Method for producing recombinant alkaline phosphatase
EP3805246A4 (en) * 2018-05-30 2022-03-23 Hybio Pharmaceutical Co., Ltd. METHODS OF PURIFICATION OF LONG-CHAIN POLYPEPTIDES
CN110845599B (zh) * 2018-08-21 2022-10-14 鲁南制药集团股份有限公司 一种多肽的制备纯化方法
WO2022029499A1 (en) 2020-08-06 2022-02-10 Ads Aiphia Development Services Ag Methods of treating refractory ascites
WO2022029497A1 (en) 2020-08-06 2022-02-10 Ads Aiphia Development Services Ag Ularitide for use in methods of treating refractory ascites
WO2022233994A1 (en) 2021-05-06 2022-11-10 Rigshospitalet Diagnosing and treating critically ill subjects

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572173B2 (en) * 1983-08-29 1988-05-05 Institut De Recherches Cliniques De Montreal Natriuretic factors
DE3346953A1 (de) * 1983-12-24 1985-08-14 Organogen Medizinisch-Molekularbiologische Forschungsgesellschaft mbH, 6900 Heidelberg Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung
JPH0780907B2 (ja) * 1984-04-19 1995-08-30 シオス・ノバ・インク 新規な心房性ナトリウム尿排泄亢進性及び血管拡張性ポリペプチド
JPH0672157B2 (ja) * 1984-08-29 1994-09-14 味の素株式会社 新規ペプチド
US5057603A (en) * 1986-01-31 1991-10-15 Merck & Co., Inc. Peptides having ANF activity
DE3878231T2 (de) * 1987-03-02 1993-05-27 Forssmann Wolf Georg Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
US5449751A (en) * 1987-03-02 1995-09-12 Pharma Bissendorf Peptide Gmbh Cardiodilatin fragment, process for preparing same and use thereof
US5204327A (en) * 1988-11-18 1993-04-20 Ashi Kasei Kogyo Kabushiki Kaisha Treatment of cerebral edema with anp pharmaceutical compositions
EP0763061B1 (de) * 1994-06-02 2002-10-30 Forssmann, Wolf-Georg, Prof. Dr. med. Verfahren zur herstellung von cardiodilatin-fragmenten, hochgereinigte cardiodilatin-fragmente und zwischenprodukte zu deren herstellung

Also Published As

Publication number Publication date
EP0763061B1 (de) 2002-10-30
EP0763061A1 (de) 1997-03-19
US20060122371A1 (en) 2006-06-08
US20100317600A1 (en) 2010-12-16
JP4130671B2 (ja) 2008-08-06
JP2005298526A (ja) 2005-10-27
JPH10500969A (ja) 1998-01-27
AU2671795A (en) 1996-01-04
US20030171536A1 (en) 2003-09-11
ATE226960T1 (de) 2002-11-15
ES2188665T3 (es) 2003-07-01
US20090240031A1 (en) 2009-09-24
US5767239A (en) 1998-06-16
WO1995033769A1 (de) 1995-12-14

Similar Documents

Publication Publication Date Title
IL113979A0 (en) Process for preparing cardiodilatin fragments highly purified cardiodilatin fragments and intermediate products for the preparation of same
EP0712862A3 (en) Selective acylation of epsilon-amino groups
CA2032153A1 (fr) Application de nouveaux fragments d'adn en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
HUP9903947A2 (hu) Eljárás neuorotrofinok tisztítására
BG101384A (en) New pesticide proteins and strains
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
HUT58764A (en) Process for producing peptides, pharmaceutical compositions containing them and amino-acid intermediates
AU1155495A (en) Process for the preparation of non-cariogenic sugars
NZ212155A (en) Purification of protein/peptide material by electroseparation
AU5155996A (en) Control of pod dehiscence
EP0192988A3 (en) Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
HUT62031A (en) Process for producing recombinant aprotinin derivatives and pharmaceutical compositions comprising same
CA2088068A1 (en) Protein structure of the plant toxin gelonin
ES8704511A1 (es) Procedimiento para sintetizar peptidos a partir de aminoaci-dos
HK1005807A1 (en) Mpl ligand analogs
WO1988003927A3 (en) Renin inhibitors
TW368505B (en) A process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same
AUPM772494A0 (en) Improvements in production of proteins in host cells
UA37217C2 (uk) Аналоги 15-дезоксиспергуаліну, спосіб їх одержання, фармацевтична композиція та проміжні сполуки
MX9700941A (es) Materiales y metodos para la produccion de icam-4.
MY105082A (en) Separation process
AU1662495A (en) Skin package
MX9505097A (es) 1,4-dihidropiridinas con estructura puente en la posicion 1,2, procedimiento para su obtencion y medicamentos que las contienen.
EP0816328A3 (en) Process for the manufacture of acetonylbenzamides